Chin Yang Chem (051630) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Chin Yang Chem KRW 1,174, price KRW 1,625, upside -27.7%, quality 33 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Chin Yang Chem for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 949.00 KRW – 7,468 KRW · fair‑value band 681.24 KRW – 1,174 KRW · the 1,625 KRW price screens above the 1,174 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Chin Yang Chem in your weekly email
Every Wednesday you see whether Chin Yang Chem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Chinyang Chemical Corporation manufactures and sells chemical products in South Korea.
Show more
Chinyang Chemical Corporation manufactures and sells chemical products in South Korea. It offers floor coverings for residential and commercial purposes; artificial leather for car seats, door trims, consoles, and headrest applications, as well as furniture; and tarpaulin for Drapery, windbreak, awning, simple tent, car shelter, beach umbrellas, livestock use, and various covers. The company was founded in 1963 and is headquartered in Ulsan, South Korea. ChinYang Chemical Corporation operates as a subsidiary of Jinyang Holdings Corp.
Stock analysis
Chin Yang Chem (051630) currently trades at 1,625 KRW, while our model-based Fair Value estimate is 1,174 KRW, implying the stock looks roughly 38.4% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 1,866 KRW per share, and 1 of the 8 models we run sit above the 1,625 KRW price.
Bear case: the Earnings-Based group reads lowest at 351.45 KRW, and 7 of the 8 models stay below the price. Evidence for this calculation is medium.
Scenario range: 681.24 KRW (bear) to 1,174 KRW (bull), the price of 1,625 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 33/100 (below-average quality), in the Basic Materials sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Chin Yang Chem reported revenue of 18.6B KRW in FY2025 versus 34.8B KRW in FY2021, a compound −14.5%/yr. Reported net income was 896M KRW in FY2025.
Key figures
Market cap 34.5B KRW (≈ $24.1M) · P/S ratio 1.92 · Net margin 4.8% · Return on equity 5.7% · Return on assets (EBIT) −4.8% · Operating margin 2.1% · Revenue (TTM) 19.1B KRW · Revenue growth (YoY) +10.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 53% below its 52-week high and 71% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −25% fair-value upside, at −28%, 051630 screens richer than that median.
Fair Value models
Bear 681.24 KRWFair Value 1,174 KRWBull 1,174 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.19/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−24.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−15.6%
Start year 2020 (pandemic). Over 10 years: −12.5% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−10.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−9.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−9.3%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.1% → −4%
⚠ Revenue per share shrinking 19.1%/yr over ~6Y (margin trend unclear) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 350 stocks
Beats the industry median on 4/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score33 · Bottom 25%
Fair Value upside−28% · Below median
Profitability
Return on equity (TTM)6% · Above median
Return on assets0% · Bottom 25%
Net margin (TTM)11% · Top 25%
Operating margin (TTM)2% · Below median
Growth and dividend
Revenue growth11% · Above median
Balance sheet
Debt / equity0.88× · Highest 25%
Valuation Multiplesvs Chemicals median · lower = cheaper
EV/EBITDA8.1× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)53· sector 24
PAST (return on equity)23· sector 19
HEALTH (low debt)56· sector 94
DIVIDEND (yield)0· sector 31
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Chin Yang Chem Fair Value". https://www.fairvalue-calculator.com/stock/051630
Frequently asked questions
Is Chin Yang Chem (051630) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 1,174 KRW versus a price of 1,625 KRW, about −28% upside (overvalued).
What is the fair value of 051630?
Our model-based fair value for Chin Yang Chem is 1,174 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 1,625 KRW.
What is the quality score of 051630?
Chin Yang Chem has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Chin Yang Chem (051630)?
Our model-based price target is the fair value of 1,174 KRW (as of Sep 24, 2026) from 9 valuation models. Cautious scenario 681.24 KRW, optimistic scenario 1,174 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Chin Yang Chem stock forecast for 2026?
Our models put fair value at 1,174 KRW, about −28% upside versus a price of 1,625 KRW (overvalued). Cautious scenario 681.24 KRW, optimistic scenario 1,174 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Chin Yang Chem (051630)?
Chin Yang Chem reported trailing-twelve-month revenue of about 19.1B KRW (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Chin Yang Chem (051630)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Chin Yang Chem it is 1,174 KRW per share (as of Sep 24, 2026), against a price of 1,625 KRW. It is the blended result of 9 valuation models (cash flow, earnings, asset, dividend).
Is Chin Yang Chem stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 051630 trades above its calculated fair value: price 1,625 KRW, fair value 1,174 KRW, a gap of about −28% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 051630?
No. The price is what the market pays today (1,625 KRW); the fair value is what the company's own numbers justify (1,174 KRW). For Chin Yang Chem the two are 450.56 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Chin Yang Chem worth?
The market values Chin Yang Chem at about 34.5B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 1,625 KRW; our models calculate a fair value of 1,174 KRW per share.
What do the bullish and bearish scenarios say about 051630?
Our models span a range for Chin Yang Chem: cautious scenario 681.24 KRW, base 1,174 KRW, optimistic 1,174 KRW per share (as of Sep 24, 2026, price 1,625 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Chin Yang Chem (051630)?
Balance-sheet figures for Chin Yang Chem (as of Sep 24, 2026): return on equity 5.7%, debt of 0.88 per unit of equity. They feed the Quality Score of 33/100, which measures business quality independently of the share price.
How far is 051630 from its 52-week high?
Chin Yang Chem trades at 1,625 KRW, about 53% below its 52-week high of 3,465 KRW and 71% above the low of 949.00 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 1,174 KRW is for.
Which stocks are comparable to Chin Yang Chem?
From the same area (Basic Materials) we also value BASF SE, Saudi Basic Industries Corporation, Ningxia Baofeng Energy Group, Dow Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Chin Yang Chem stock attractive at the current price?
The data as of Sep 24, 2026: price 1,625 KRW, calculated fair value 1,174 KRW (−28%), Quality Score 33/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 051630 calculated?
We run Chin Yang Chem through 9 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1,174 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Chin Yang Chem itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Chin Yang Chem (051630)?
The closing price on Sep 23, 2026 was 1,625 KRW. Our model-based fair value is 1,174 KRW, about −28% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Chin Yang Chem right now?
The price sits above even our optimistic bull case (1,174 KRW). The favourable scenario is already priced in. Weak quality (33/100) and above fair value at the same time, the margin of safety is missing on both counts.
Key figures of Chin Yang Chem
How large is the market capitalisation of Chin Yang Chem (051630)?
The market capitalisation of Chin Yang Chem is 34.5B KRW (≈ $24.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Chin Yang Chem (051630)?
The price-to-sales ratio of Chin Yang Chem is 1.92 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Chin Yang Chem (051630)?
The net margin of Chin Yang Chem is 4.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Chin Yang Chem (051630)?
The return on equity (ROE) of Chin Yang Chem is 5.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Chin Yang Chem (051630)?
On an EBIT basis the return on assets of Chin Yang Chem is −4.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Chin Yang Chem (051630)?
The operating margin of Chin Yang Chem is 2.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Chin Yang Chem (051630)?
Revenue at Chin Yang Chem is growing +10.5% versus a year earlier (3y avg −13.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Chin Yang Chem (051630)?
Earnings per share at Chin Yang Chem are growing +449% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Chin Yang Chem (051630) generate?
The free cash flow of Chin Yang Chem is −1.1B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Chin Yang Chem (051630) carry?
The net debt of Chin Yang Chem is 11.7B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Chin Yang Chem in the live analysis
One click puts Chin Yang Chem on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
